A model of binge-like eating behavior in mice that does not require food deprivation or stress.
Czyzyk
Traci A
TA
Obesity Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, USA. czyzyk-morgantr@lilly.com
Sahr
Allison E
AE
Statnick
Michael A
MA
D050154:Adiposity / Q000502:physiology; D000818:Animals; D019440:Anti-Obesity Agents / Q000494:pharmacology; D001418:Baclofen / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D056912:Binge-Eating Disorder / Q000188:drug therapy / Q000503:physiopathology; D001835:Body Weight / Q000502:physiology; D004032:Diet; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D002149:Energy Intake / Q000187:drug effects / Q000502:physiology*; D005473:Fluoxetine / Q000494:pharmacology / Q000627:therapeutic use; D005632:Fructose / Q000031:analogs & derivatives / Q000494:pharmacology; D058786:GABA-B Receptor Agonists / Q000494:pharmacology; D006185:Habituation, Psychophysiologic; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000077236:Topiramate
D019440:Anti-Obesity Agents; D001418:Baclofen; D005473:Fluoxetine; D005632:Fructose; D058786:GABA-B Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D000077236:Topiramate